Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Dotinurad receives Japanese approval for hyperuricemia

Jan. 24, 2020

Japanese approval of Dinagest for dysmenorrhea

Jan. 23, 2020

AKCEA-APOCIII-LRx meets primary endpoint in phase II hypertriglyceridemia trial

Jan. 23, 2020

Phase I study initiated for REN-001 in McArdle disease

Jan. 22, 2020

Boehringer Ingelheim presents GPR142 agonists

Jan. 22, 2020

Yale University divulges let-7 microRNA-activating compounds for endometriosis

Jan. 22, 2020

FDA clears IND application for KAN-101 for the treatment of celiac disease

Jan. 22, 2020

FDA approves Polaryx's IND for PLX-200 in LINCL

Jan. 21, 2020

Tufts Medical Center divulges CDK6 inhibitors

Jan. 21, 2020

Cord blood cells improve islet transplantation outcomes

Jan. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...